Share to: share facebook share twitter share wa share telegram print page

Intravenous ascorbic acid

Intravenous ascorbic acid
Intravenous bag and drip chamber on a pole, used to administer ascorbic acid solution through peripheral IV line
Other namesVitamin C, Ascorbate, L-ascorbic acid, pharmacologic ascorbic acid PAA
ICD-10-PCSZ51.81
ICD-9-CM267

Intravenous Ascorbic Acid or PAA, pharmacologic ascorbic acid[1] (also known as vitamin C or L-ascorbic acid), is a process that delivers soluble ascorbic acid directly into the bloodstream. It is not approved for use to treat any medical condition.[2]

The use of intravenous ascorbic acid as a proposed cancer treatment or co-treatment has been a controversial topic since the emergence of misleading data in the 1970s.[3]

Contraindications

High doses of ascorbic acid administered by intravenous infusion have been shown to increase the absorption of iron.[4] In individuals with hemochromatosis (a genetic disorder where the body takes up and stores too much iron), intravenous ascorbic acid is contraindicated as high dosages of ascorbic acid may result in iron overloading and therefore, lead to life-threatening complications such as heart disease, diabetes, or tissue damage.[5]

High dosages of ascorbic acid (such as those used in intravenous therapy) have been reported to cause some intestinal discomfort, diarrhoea, as well as increased gas and urination.[6]

Alternative medicine and unproven applications

Sepsis

The "Marik protocol", or "HAT" protocol, as devised by Paul E. Marik, proposed a combination of intravenous vitamin C, hydrocortisone, and thiamine as a treatment for preventing sepsis for people in intensive care. Marik's own initial research, published in 2017,[7] showed a dramatic evidence of benefit, leading to the protocol becoming popular among intensive care physicians,[8] especially after the protocol received attention on social media and National Public Radio, drawing criticism of science by press conference from the wider medical community.[9][10] Subsequent independent research failed to replicate Marik's positive results, indicating the possibility that they had been compromised by bias.[10][11] A systematic review of trials in 2021 found that the claimed benefits of the protocol could not be confirmed.[12]

People in sepsis may have micronutrient deficiencies, including low levels of vitamin C.[13] Reviews mention that an intake of 3.0 g/day via intravenous administration may needed to maintain normal plasma concentrations.[14][15] Sepsis mortality is reduced with administration of intravenous vitamin C.[16]

Pharmacology

Chemical structure of ascorbic acid (reduced form)

Mechanism of action

Ascorbic acid operates as an anti-oxidant and essential enzyme cofactor in the human body. In in vitro studies, the primary mechanism of high dosage intravenous ascorbic acid can be related to ascorbic acid's pro-oxidant activity, whereby hydrogen peroxide is formed.[17][18][19] In the extracellular fluid of cells, ascorbic acid dissociates into an ascorbate radical upon the reduction of transition metal ions, such as ferric or cupric cations.[17] These transition metal ions will then reduce dissolved oxygen into a superoxide radical – this will then react with hydrogen to form hydrogen peroxide.[18]

Furthermore, according to Fenton chemistry, these transition metal ions can be further oxidised by hydrogen peroxide to generate a highly reactive hydroxyl radical.[20] The formation of hydrogen peroxide and hydroxyl radicals is believed to induce cytotoxicity and apoptosis of cancer cells.[20] Although many in vitro studies have studied hydrogen peroxide generation by ascorbic acid, the pharmacological mechanism of intravenous ascorbic acid in vivo is still unclear.[20]

History

Pioneering research

Although the pharmacology of ascorbic acid had been studied since its discovery in the 1930s,[21] the method of administration and its medicinal potential to human patients was not investigated until the 1940s.[22] In 1949, American physician, Frederick Klenner, published his scientific report, “The Treatment of Poliomyelitis and Other Virus Diseases with ascorbic acid”,[23] which detailed the use of intravenous ascorbic acid to treat polio in children.[22] Klenner's research pioneered future studies investigating the medicinal role of intravenous ascorbic acid. Klenner's work was recognised by Linus Pauling in the foreword to the Clinical Guide: "Dr. Fred Klenner's early research reports provide much information on the use of high-dose ascorbic acid for the prevention and cure of many diseases, and these reports are still important."[24]

Black and white photo of Nobel Prize winner, Linus Pauling.
Nobel Prize winner, Linus Pauling, is recognised as one of the early pioneers of ascorbic acid research

Linus Pauling

Nobel Prize winner and biochemist, Linus Pauling, was pivotal in the re-emergence of intravenous ascorbic acid research. Over the course of the 1970s, Pauling would begin a long-term collaboration with fellow physician, Ewan Cameron, on the medical potential of intravenous ascorbate acid as cancer therapy in terminally ill patients. In 1976, Pauling and Cameron co-authored a study whereby a group of 100 terminal cancer patients underwent supplementary ascorbic acid therapy (10g/day by intravenous infusion and oral thereafter) and the control group of 1,000 patients did not.[25] Their findings reported that the survival rate of the terminal cancer patients increased by four-fold, compared to the control group, stating that: "the treatment of ascorbate in amounts of 10g/day or more is of real value in extending the life of patients with advanced cancer."[25]

Subsequent studies by Pauling and Cameron hypothesised that ascorbic acid's role in enhanced collagen production would lead to the encapsulation of tumours and thus, protect normal tissue from metastasis.[26] Following these findings, Pauling became a strong advocate for vitamin megadosing and continued to investigate the medicinal potential of intravenous ascorbic acid across a range of illnesses, including: HIV transmission, the common cold, atherosclerosis, and angina pectoris.[27][28][29]

Medical controversy

The efficacy of intravenous ascorbic acid therapy came under scrutiny of the medical and science community, following the numerous high-profile studies authored by Linus Pauling in the 1970s.[19] The experimental design of Pauling and Cameron's 1976 publication, "Supplemental ascorbate in the supportive treatment of cancer",[25] had garnered considerable criticism as it was neither randomised nor placebo controlled. To test the validity of Pauling and Cameron's findings, the Mayo Clinic conducted three independent experiments in 1979, 1983 and 1985, whereby terminal cancer patients were given doses of oral ascorbic acid under randomised, double bind and placebo-controlled conditions.[30][31][32] All studies concluded that high doses of oral ascorbic acid were not effective against cancer.

The use of intravenous ascorbic acid in the treatment of cancer has been a contentious issue. There is no evidence to indicate that intravenous ascorbic acid therapy can cure cancer.[33][32] According to the U.S. Food and Drug Administration (FDA), high-dose vitamin C (such as intravenous ascorbic acid therapy) has not been approved as a treatment for cancer or any other medical condition.[2]

There many been multiple studies devoted to investigating the medicinal properties of ascorbic acid. The use of high-dosage intravenous ascorbic acid as a cancer treatment was first promoted by Linus Pauling and Ewan Cameron in the 1970s;[25][26] however, these findings were not reproduced using oral administration by subsequent Mayo Clinic studies in the 1980s.[30][31][32] In 2010, an academic review which detailed 33 years of ascorbic acid and cancer research stated: "we still do not know whether Vitamin C has any clinically significant anti-tumor activity. Nor do we know which histological types of cancers, if any, are susceptible to this agent. Finally, we don't know what the recommended dose of Vitamin C is, if there is indeed such a dose, that can produce an anti-tumor response".[34]

Research

The turn of the 21st century saw a renewed interest in the medical potential of intravenous ascorbic acid therapy. In the early 2010s, in vitro preclinical and clinical trials were undertaken to investigate the pharmacological mechanism of action of intravenous ascorbic acid therapy.[35][36] These findings demonstrated ascorbic acid's pro-oxidant capabilities to produce hydrogen peroxide and thus, proposed a possible pharmacological mechanism of action against cancer cells. Nonetheless, ascorbic acid's potential as an anti-tumour therapy is still dubious, as other pro-oxidant substances (such as menadione[37][38]) have been unsuccessful in the treatment of cancer patients.[39]

See also

References

  1. ^ "Treatment of pancreatic cancer with intravenous vitamin C: a case report, Jeanne A. Drisco et. al, published in Anti Cancer Drugs 2018 vol 29 No 4
  2. ^ a b "The Vitamin C Foundation – 514071 – 04/17/2017". U.S. Food and Drug Administration. 2019-04-23. Retrieved 2019-06-07.
  3. ^ Nabzdyk CS, Bittner EA (October 2018). "Vitamin C in the critically ill – indications and controversies". World Journal of Critical Care Medicine. 7 (5): 52–61. doi:10.5492/wjccm.v7.i5.52. PMC 6201324. PMID 30370227.
  4. ^ Jacob RA, Sotoudeh G (March 2002). "Vitamin C function and status in chronic disease". Nutrition in Clinical Care. 5 (2): 66–74. doi:10.1046/j.1523-5408.2002.00005.x. PMID 12134712.
  5. ^ Institute of Medicine (US) Panel on Dietary Antioxidants Related Compounds (2000-04-11). Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. doi:10.17226/9810. ISBN 9780309069359. PMID 25077263.
  6. ^ Ohno S, Ohno Y, Suzuki N, Soma G, Inoue M (March 2009). "High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer". Anticancer Research. 29 (3): 809–815. PMID 19414313.
  7. ^ Marik, Paul E.; Khangoora, Vikramjit; Rivera, Racquel; Hooper, Michael H.; Catravas, John (2017). "Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock". Chest. 151 (6). Elsevier BV: 1229–1238. doi:10.1016/j.Chest.2016.11.036. ISSN 0012-3692. PMID 27940189. S2CID 3509326.
  8. ^ "The Marik Protocol: Have We Found a "Cure" for Severe Sepsis and Septic Shock?". Rebel EM – Emergency Medicine Blog. 2017-04-07. Retrieved 2021-07-22.
  9. ^ "Vitamin C Drug Cocktail for Sepsis". HealthManagement. July 9, 2019. Retrieved 2021-09-24.
  10. ^ a b Rubin R (July 2019). "Wide Interest in a Vitamin C Drug Cocktail for Sepsis Despite Lagging Evidence". JAMA. 322 (4): 291–293. doi:10.1001/jama.2019.7936. PMID 31268477. S2CID 195788169.
  11. ^ ""Ethically and morally unacceptable": Reaction to vitamin C for sepsis trial". Dietary supplements, Nutraceuticals, Functional foods, Health ingredients, Herbals. 2020-01-28. Retrieved 2021-07-22.
  12. ^ Lee YR, Vo K, Varughese JT (May 2021). "Benefits of combination therapy of hydrocortisone, ascorbic acid and thiamine in sepsis and septic shock: A systematic review". Nutr Health. 28 (1): 77–93. doi:10.1177/02601060211018371. PMID 34039089. S2CID 235215735.
  13. ^ Belsky JB, Wira CR, Jacob V, Sather JE, Lee PJ (December 2018). "A review of micronutrients in sepsis: the role of thiamine, L-carnitine, vitamin C, selenium and vitamin D". Nutrition Research Reviews. 31 (2): 281–90. doi:10.1017/S0954422418000124. PMID 29984680. S2CID 51599526.
  14. ^ Liang B, Su J, Shao H, Chen H, Xie B (March 2023). "The outcome of IV vitamin C therapy in patients with sepsis or septic shock: a meta-analysis of randomized controlled trials". Crit Care. 27 (1): 109. doi:10.1186/s13054-023-04392-y. PMC 10012592. PMID 36915173.
  15. ^ Berger MM, Oudemans-van Straaten HM (March 2015). "Vitamin C supplementation in the critically ill patient". Curr Opin Clin Nutr Metab Care. 18 (2): 193–201. doi:10.1097/MCO.0000000000000148. PMID 25635594. S2CID 37895257.
  16. ^ Xu C, Yi T, Tan S, Xu H, Hu Y, Ma J, Xu J (April 2023). "Association of Oral or Intravenous Vitamin C Supplementation with Mortality: A Systematic Review and Meta-Analysis". Nutrients. 15 (8): 1848. doi:10.3390/nu15081848. PMC 10146309. PMID 37111066.
  17. ^ a b Carr AC, Cook J (2018-08-23). "Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge". Frontiers in Physiology. 9: 1182. doi:10.3389/fphys.2018.01182. PMC 6115501. PMID 30190680.
  18. ^ a b Vissers MC, Das AB (2018-07-03). "Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence". Frontiers in Physiology. 9: 809. doi:10.3389/fphys.2018.00809. PMC 6037948. PMID 30018566.
  19. ^ a b Verrax J, Calderon PB (December 2008). "The controversial place of vitamin C in cancer treatment". Biochemical Pharmacology. 76 (12): 1644–1652. doi:10.1016/j.bcp.2008.09.024. PMID 18938145.
  20. ^ a b c Fritz H, Flower G, Weeks L, Cooley K, Callachan M, McGowan J, et al. (July 2014). "Intravenous Vitamin C and Cancer: A Systematic Review". Integrative Cancer Therapies. 13 (4): 280–300. doi:10.1177/1534735414534463. PMID 24867961.
  21. ^ Carpenter KJ (2012). "The discovery of vitamin C". Annals of Nutrition & Metabolism. 61 (3): 259–264. doi:10.1159/000343121. PMID 23183299. S2CID 37436503.
  22. ^ a b "Intravenous Vitamin C: The Historical Progression". PaulingBlog. 2017-10-18. Retrieved 2019-05-20.
  23. ^ "The Treatment of Poliomyelitis and Other Virus Diseases with Vitamin C". www.seanet.com. Retrieved 2019-05-20.
  24. ^ "Clinical Guide to the Use of Vitamin C". www.seanet.com. Retrieved 2019-05-20.
  25. ^ a b c d Cameron E, Pauling L (October 1976). "Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer". Proceedings of the National Academy of Sciences of the United States of America. 73 (10): 3685–3689. Bibcode:1976PNAS...73.3685C. doi:10.1073/pnas.73.10.3685. PMC 431183. PMID 1068480.
  26. ^ a b Mikirova N, Casciari J, Riordan N, Hunninghake R (August 2013). "Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients". Journal of Translational Medicine. 11: 191. doi:10.1186/1479-5876-11-191. PMC 3751545. PMID 23947403.
  27. ^ Pauling L (January 1973). "Ascorbic acid and the common cold". Scottish Medical Journal. 18 (1): 1–2. doi:10.1177/003693307301800101. PMID 4577802. S2CID 28875346.
  28. ^ Harakeh S, Jariwalla RJ, Pauling L (September 1990). "Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells". Proceedings of the National Academy of Sciences of the United States of America. 87 (18): 7245–7249. Bibcode:1990PNAS...87.7245H. doi:10.1073/pnas.87.18.7245. PMC 54720. PMID 1698293.
  29. ^ Rath M, Pauling L (August 1990). "Hypothesis: lipoprotein(a) is a surrogate for ascorbate". Proceedings of the National Academy of Sciences of the United States of America. 87 (16): 6204–6207. Bibcode:1990PNAS...87.6204R. doi:10.1073/pnas.87.16.6204. PMC 54501. PMID 2143582.
  30. ^ a b Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S (September 1979). "Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial". The New England Journal of Medicine. 301 (13): 687–690. doi:10.1056/NEJM197909273011303. PMID 384241.
  31. ^ a b Tschetter L, Creagan E, O'Fallon J (1983). "A community-based study of vitamin C (ascorbic acid) in patients with advanced cancer". Proceedings of the American Society of Clinical Oncology. 2: 92.
  32. ^ a b c Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM (January 1985). "High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison". The New England Journal of Medicine. 312 (3): 137–141. doi:10.1056/NEJM198501173120301. PMID 3880867.
  33. ^ Klimant E, Wright H, Rubin D, Seely D, Markman M (April 2018). "Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach". Current Oncology. 25 (2): 139–148. doi:10.3747/co.25.3790. PMC 5927785. PMID 29719430.
  34. ^ Cabanillas F (September 2010). "Vitamin C and cancer: what can we conclude – 1,609 patients and 33 years later?". Puerto Rico Health Sciences Journal. 29 (3): 215–217. PMID 20799507.
  35. ^ Parrow NL, Leshin JA, Levine M (December 2013). "Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics". Antioxidants & Redox Signaling. 19 (17): 2141–2156. doi:10.1089/ars.2013.5372. PMC 3869468. PMID 23621620.
  36. ^ Fritz H, Flower G, Weeks L, Cooley K, Callachan M, McGowan J, et al. (July 2014). "Intravenous Vitamin C and Cancer: A Systematic Review". Integrative Cancer Therapies. 13 (4): 280–300. doi:10.1177/1534735414534463. PMID 24867961.
  37. ^ Tetef M, Margolin K, Ahn C, Akman S, Chow W, Leong L, et al. (1995). "Mitomycin C and menadione for the treatment of lung cancer: a phase II trial". Investigational New Drugs. 13 (2): 157–162. doi:10.1007/BF00872865. PMID 8617579. S2CID 10086469.
  38. ^ Margolin KA, Akman SA, Leong LA, Morgan RJ, Somlo G, Raschko JW, et al. (1995). "Phase I study of mitomycin C and menadione in advanced solid tumors". Cancer Chemotherapy and Pharmacology. 36 (4): 293–298. doi:10.1007/BF00689046. PMID 7628048. S2CID 7283959.
  39. ^ Borst P (December 2008). "Mega-dose vitamin C as therapy for human cancer?". Proceedings of the National Academy of Sciences of the United States of America. 105 (48): E95, author reply E96. Bibcode:2008PNAS..105E..95B. doi:10.1073/pnas.0809328105. PMC 2596258. PMID 19033231.

Read other articles:

Ioannes beralih ke halaman ini. Untuk orang lain, lihat Ioannes (nama pemberian).IoannesKaisar Romawi BaratBerkuasa20 November 423 – Mei 425PendahuluHonoriusPenerusValentinianus IIIInformasi pribadiKelahiranabad ke-4Kematiansek. Mei 425Aquileia Ioannes (meninggal 425) adalah kaisar Romawi Barat dari tahun 423 hingga 425, Ioannes adalah seorang primicerius notariorum atau pegawai negeri senior pada saat pengangkatannya. Procopius memujinya sebagai baik lembut dan baik diberkahi dengan kebijaksa…

InangPoster rilis teatrikalNama lainThe WombSutradaraFajar NugrosProduserSusanti DewiDitulis olehDeo MahameruPemeran Naysilla Mirdad Dimas Anggara Rukman Rosadi Lydia Kandou Rania Putrisari Pritt Timothy Nungki Kusumastuti Totos Rasiti Penata musik Aghi Narottama Bemby Gusti Tony Merle SinematograferWendy AgaPenyuntingWawan I. WibowoPerusahaanproduksiIDN PicturesTanggal rilis 7 Juli 2022 (2022-07-07) (Korea Selatan) 13 Oktober 2022 (2022-10-13) (Indonesia) 24 Novemb…

Lauren Lauren Arsenal menguasai stadion nasional Singapura 2017Informasi pribadiNama lengkap Lauren Etame MayerTanggal lahir 19 Januari 1977 (umur 47)Tempat lahir Kribi, KamerunTinggi 1,80 m (5 ft 11 in)Posisi bermain BekKarier senior*Tahun Tim Tampil (Gol)1995–1996 Utrera 30 (5)1996–1997 Sevilla B 17 (3)1997–1998 Levante 34 (6)1998–2000 Mallorca 63 (4)2000–2006 Arsenal 159 (7)2006–2009 Portsmouth 25 (0)2010 Córdoba 5 (0)Total 333 (25)Tim nasional1997–2006[…

Golden Globe Awards ke-75Poster resmiTanggal7 Januari 2018TempatThe Beverly Hilton,Beverly Hills, California, A.S.Pembawa acaraSeth MeyersSorotanFilm Terbaik: DramaThree Billboards Outside Ebbing, MissouriFilm Terbaik: Musikal atau KomediLady BirdSeri Drama TerbaikThe Handmaid's TaleSeri Musikal atau Komedi TerbaikThe Marvelous Mrs. MaiselMiniseri atau Film Televisi TerbaikBig Little LiesPenghargaan terbanyakThree Billboards Outside Ebbing, MissouriBig Little Lies (4)Nominasi terbanyakThe Shape …

Banzai JKT48 (バンザイJKT48code: ja is deprecated ) adalah setlist pertunjukan teater dari grup idola Indonesia JKT48. Setlist ini merupakan setlist spesial sebagai bentuk dalam menyambut 10 tahun atau 1 dasawarsa JKT48 pada 17 Desember 2021 yang lalu. Setlist ini dipentaskan dalam bentuk pertunjukan yang berasal dari album, singel, dan pertunjukan setlist dari 4 grup idola dari AKB48 Group di Jepang (seperti AKB48, SKE48, NMB48, dan HKT48) dan diterjemahkan ke dalam Bahasa Indonesia. Saat i…

Disambiguazione – Se stai cercando altri significati, vedi Addome (disambigua). AddomeNome latinoAbdomen IdentificatoriMeSHA01.923.047 TAA01.1.00.016 FMA9577 Modifica dati su Wikidata · Manuale L'addome o ventre o pancia è una parte costituente il corpo (o tronco) di un animale o persona, dove sono racchiusi i visceri (intestino, stomaco, fegato, pancreas e reni). La regione occupata dall'addome è chiamata cavità addominale, ed è la più ampia cavità dell'organismo umano, delimitata…

Filipino rock band This article is about the Filipino rock band. For other uses, see The Dawn. Not to be confused with Dawn (Swedish band). The DawnThe Dawn ca. late 80's (L-R, front to rear) the late Teddy Diaz (guitar), Jett Pangan (vocals), JB Leonor (drums) and Carlos Balcells (bass guitar)Background informationOriginManila, PhilippinesGenres Pinoy rock new wave (early work) Years active 1985–1995 1999–present LabelsMCA MusicSony BMG PhilippinesWarner Music PhilippinesIvory Music & V…

Foto Perkampungan Prapatan Prapatan TulungDesaNegara IndonesiaProvinsiJawa TengahKabupatenKlatenKecamatanTulungKode pos57482Kode Kemendagri33.10.19.2013 Luas... km²Jumlah penduduk... jiwaKepadatan... jiwa/km² Prapatan Tulung adalah dukuh di bagian desa Tulung, Klaten, Jawa Tengah, Indonesia. Asal-muasal dukuh berdiri sekitar akhir tahun 1950-an, pada awalnya wilayah ini berupa persawahan di pinggir jalan. Status menempati tanah sewa dengan sebidang sawah, setelah kurun waktu tanah akhirny…

Two-Fisted TalesSampul DVD JepangSutradaraRichard DonnerTom HollandRobert ZemeckisProduser Richard Donner David Giler Walter Hill Joel Silver William Teitler Robert Zemeckis SkenarioGilbert AdlerFrank Darabont (Showdown)Randall Jahnson (King of the Road)Jim Thomas (Yellow)John Thomas (Yellow)BerdasarkanTwo-Fisted Talesoleh Harvey KurtzmanPemeran William Sadler David Morse Brad Pitt Kirk Douglas Lance Henriksen Dan Aykroyd Penata musikMichael Kamen (Showdown)Warren Zevon (King of the Road)A…

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: Stichting Ether Reclame – news · newspapers · books · scholar · JSTOR (May 2012) (Learn how and when to remove this template message) Stichting Ether ReclameSTER's current logo since 8 November 2001.TypePublic broadcasterCountryNetherlandsAvailabilityNetherlandsFo…

Japanese anime television series Not to be confused with Concrete Revolution. Concrete Revolutio:Superhuman Phantasmagoriaコンクリート・レボルティオ~超人幻想~(Konkurīto Reborutio: Chōjin Gensō)GenreSuperhero[1]Created byBonesShō Aikawa Anime television seriesDirected bySeiji MizushimaProduced byYoshihiro ŌyabuMinoru TakanashiHirotaka KanekoHirotsugu OgisuRyōsuke NakajiTsutomu YanagimuraTakuya HosakaWritten byShō AikawaMasaki TsujiMusic …

Majko II Government61st Government of AlbaniaDate formed22 February 2002 (2002-02-22)Date dissolved31 July 2002 (2002-07-31)People and organisationsPresidentRexhep MeidaniAlfred MoisiuChairpersonNamik DoklePrime MinisterPandeli MajkoDeputy Prime MinisterSkënder GjinushiTotal no. of members140Member partiesPSStatus in legislatureCoalitionOpposition partiesPD, PROpposition leaderSali BerishaHistoryElection(s)2001 electionPredecessorMeta II GovernmentSuccessorNano IV …

Series of steam locomotives built 1919–1921 Highland Railway Clan classNo. 49 Clan CampbellType and originPower typeSteamDesignerChristopher CummingBuilderR. & W. Hawthorn, Leslie and CompanySerial number3329–3332, 3443–3446Build date1919 (4), 1921 (4)Total produced8SpecificationsConfiguration:​ • Whyte4-6-0 • UIC2′C h2Gauge4 ft 8+1⁄2 in (1,435 mm) standard gaugeLeading dia.3 ft 0 in (0.914 m)Driver dia.6 ft…

Questa voce sull'argomento calciatori belgi è solo un abbozzo. Contribuisci a migliorarla secondo le convenzioni di Wikipedia. Segui i suggerimenti del progetto di riferimento. Alfons Van Brandt Nazionalità  Belgio Altezza 168 cm Calcio Ruolo Difensore Termine carriera 1959 Carriera Squadre di club1 1945-1959 Lierse319 (6) Nazionale 1950-1957 Belgio38 (0) 1 I due numeri indicano le presenze e le reti segnate, per le sole partite di campionato.Il simbolo → indica un trasferimen…

Raul KhajimbaРауль Ҳаџьымба რაულ ხაჯიმბა Presiden Abkhazia ke-4Masa jabatan25 September 2014 – 12 Januari 2020Perdana MenteriBeslan ButbaArtur MikvabiaBeslan BartsitsShamil Adzynba (Pelaksana tugas)Gennadi GaguliaDaur Arshba (Pelaksana tugas)Valeri BganbaWakil PresidenVitali Gabnia Aslan BartsitsPendahuluAlexander AnkvabPenggantiValeri Bganba (Pelaksana tugas)Anggota Parlemenuntuk dapil no. 30 (Tkvarcheli)Masa jabatan3 April 2012 – 7 Oktob…

この記事は検証可能な参考文献や出典が全く示されていないか、不十分です。出典を追加して記事の信頼性向上にご協力ください。(このテンプレートの使い方)出典検索?: コルク – ニュース · 書籍 · スカラー · CiNii · J-STAGE · NDL · dlib.jp · ジャパンサーチ · TWL(2017年4月) コルクを打ち抜いて作った瓶の栓 コルク(木栓、蘭&…

この記事は検証可能な参考文献や出典が全く示されていないか、不十分です。出典を追加して記事の信頼性向上にご協力ください。(このテンプレートの使い方)出典検索?: コルク – ニュース · 書籍 · スカラー · CiNii · J-STAGE · NDL · dlib.jp · ジャパンサーチ · TWL(2017年4月) コルクを打ち抜いて作った瓶の栓 コルク(木栓、蘭&…

German actor, playwright and inventor Alois SenefelderLithograph of Senefelder, from Specimens of Polyautography.BornAloys Johann Nepomuk Franz Senefelder6 November 1771Prague, Kingdom of BohemiaDied26 February 1834 (aged 62)Munich, Kingdom of BavariaNationalityGermanKnown forInventing lithographyParentPeter Senefelder (father) Johann Alois Senefelder (6 November 1771 – 26 February 1834) was a German actor and playwright who invented the printing technique of lithography in t…

1900年美國總統選舉 ← 1896 1900年11月6日 1904 → 447張選舉人票獲勝需224張選舉人票投票率73.2%[1] ▼ 6.1 %   获提名人 威廉·麥金利 威廉·詹寧斯·布賴恩 政党 共和黨 民主党 家鄉州 俄亥俄州 內布拉斯加州 竞选搭档 西奧多·羅斯福 阿德萊·史蒂文森一世 选举人票 292 155 胜出州/省 28 17 民選得票 7,228,864 6,370,932 得票率 51.6% 45.5% 總統選舉結果地圖,紅色代表麥…

For other uses, see Tasek Gelugor (disambiguation). Suburb of Seberang Perai in Penang, MalaysiaTasek GelugorSuburb of Seberang PeraiOther transcription(s) • Mandarin打昔汝莪 • HokkienTá-sek-lú-gô (Tâi-lô) • Tamilதாசேக் குளுகோர்Tācēk Kuḷukōr (Transliteration)Location within    Seberang Perai in    PenangTasek GelugorCoordinates: 5°29′0″N 100°30′0″E / 5.48333°N 100.500…

Kembali kehalaman sebelumnya